# PSD502 in Subjects With Premature Ejaculation

> **NCT03578783** · PHASE2 · COMPLETED · sponsor: **Plethora Solutions Ltd** · enrollment: 121 (actual)

## Conditions studied

- Premature Ejaculation

## Interventions

- **DRUG:** Placebo
- **DRUG:** PSD502

## Key facts

- **NCT ID:** NCT03578783
- **Lead sponsor:** Plethora Solutions Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-26
- **Primary completion:** 2021-05-04
- **Final completion:** 2021-12-01
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2022-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03578783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03578783, "PSD502 in Subjects With Premature Ejaculation". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03578783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*